Integra LifeSciences Holdings Co (NASDAQ: IART). Extremely significant negative changes in investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, and the stock fell on very heavy volume.
Minimal negative changes in Integra LifeSciences Holdings Co (NASDAQ: IART) fundamentals have recently occurred: significant quarterly sales deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, IART is expected to continue to be an important Value Builder.
Integra LifeSciences Holdings has a current Value Trend Rating of C (Neutral). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Integra LifeSciences Holdings has a slightly positive Appreciation Score of 61 and a neutral Power Rating of 49, and the Neutral Value Trend Rating results.
Recent Price Action
Integra LifeSciences Holdings Co (NASDAQ: IART) stock closed at $36.91 on 2/29/24 after a decline of -4.6%. Moreover, exceptionally high trading volume at 409% of normal accompanied the decline. The stock has performed in line with the market over the last nine months and has declined -17.5% during the last week.
Be the first to comment